Preclinical SPECT and SPECT-CT in Oncology. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer Franc, B. L., Seo, Y., Flavell, R., Aparici, C. M. 2020; 216: 359–404


Molecular imaging enables both spatial and temporal understanding of the complex biologic systems underlying carcinogenesis and malignant spread. Single-photon emission tomography (SPECT) is a versatile nuclear imaging-based technique with ideal properties to study these processes in vivo in small animal models, as well as to identify potential drug candidates and characterize their antitumor action and potential adverse effects. Small animal SPECT and SPECT-CT (single-photon emission tomography combined with computer tomography) systems continue to evolve, as do the numerous SPECT radiopharmaceutical agents, allowing unprecedented sensitivity and quantitative molecular imaging capabilities. Several of these advances, their specific applications in oncology as well as new areas of exploration are highlighted in this chapter.

View details for DOI 10.1007/978-3-030-42618-7_11

View details for PubMedID 32594393